Thomas Schlaich, Dipl. Ing. FH
Janssen Vaccine AG
Manufacturing Specialist Lead SC
<ul>
<li>Born 1975 in Basel, Switzerland</li>
<li>From 1997 to 2001 studying at the University of Applied Science, Wädenswil</li>
<li>Holds a degree in Biotechnology Engineering</li>
<li>From 2001 to 2005 working as Scientist at the Federal Institute of Technology in Zurich</li>
<li>In 2005 starting as Upstream Teamleader in the Hepatitis A production at Berna Biotech AG in Bern</li>
<li>Between 2009 and 2014 Working as Project Planner and Project Manager at Crucell Switzerland AG (former Berna Biotech AG). During this time responsible for Working Cell Bank production, launch of new active pharmaceutical ingredients from external suppliers, technology transfer and support in building up a new GMP building for a Hepatitis A production for capacity increase</li>
<li>In 2014 Leading the phase out of the Hepatitis A production in Bern</li>
<li>In September 2014 representing Operations in the Core Team for the fast track project for the refurbishment of Building 81J for Ebola Vaccine Production</li>
<li>Since 2015 Working as Manufacturing Specialist Lead Supply Chain in the department of the vaccine production at Janssen Vaccines AG in Bern (former Crucell Switzerland AG)</li>
</ul>
<li>Born 1975 in Basel, Switzerland</li>
<li>From 1997 to 2001 studying at the University of Applied Science, Wädenswil</li>
<li>Holds a degree in Biotechnology Engineering</li>
<li>From 2001 to 2005 working as Scientist at the Federal Institute of Technology in Zurich</li>
<li>In 2005 starting as Upstream Teamleader in the Hepatitis A production at Berna Biotech AG in Bern</li>
<li>Between 2009 and 2014 Working as Project Planner and Project Manager at Crucell Switzerland AG (former Berna Biotech AG). During this time responsible for Working Cell Bank production, launch of new active pharmaceutical ingredients from external suppliers, technology transfer and support in building up a new GMP building for a Hepatitis A production for capacity increase</li>
<li>In 2014 Leading the phase out of the Hepatitis A production in Bern</li>
<li>In September 2014 representing Operations in the Core Team for the fast track project for the refurbishment of Building 81J for Ebola Vaccine Production</li>
<li>Since 2015 Working as Manufacturing Specialist Lead Supply Chain in the department of the vaccine production at Janssen Vaccines AG in Bern (former Crucell Switzerland AG)</li>
</ul>